Status of biomarker development for frontotemporal dementia and amyotrophic lateral sclerosis
Yue Yang1
Qi Cheng2
Jianqun Gao3
Woojin Scott Kim1
1.Brain and Mind Centre & School of Medical Sciences,The University of Sydney,Sydney,NSW,Australia2.Department of Neurology and Neurophysiology,Liverpool Hospital,Sydney,NSW,Australia;Stroke and Neurology Research Group,Ingham Institute for Applied Medical Research,Sydney,NSW,Australia3.Shanghai Key Laboratory of Anesthesiology and Brain Functional Modulation,Shanghai,China;Clinical Research Center for Anesthesiology and Perioperative Medicine,Shanghai,China;Translational Research Institute of Brain and Brain-Like Intelligence,Shanghai Fourth People's Hospital,School of Medicine,Tongji University,Shanghai,China
摘要：Frontotemporal dementia(FTD)and amyotrophic lateral sclerosis(ALS)are neurodegenerative diseases that belong to the same disease spectrum,with overlapping of genetic and pathological features.Genetic mutations in TARDBP,C9ORF72,MA PT,and GRN have been identified in these diseases.
机标关键词：developmentamyotrophicbiomarkerdementiafrontotemporallateralsclerosisstatus
论文发表日期：2024-10-28
在线出版日期：2025-08-15（本平台首次上网日期，不代表文献的发表时间）
页数：2( 2117-2118 )